TRU-SENTIMENT · DeltaNeutral
ERAS Trading Analysis - 09/18/2026 01:41 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ERAS (Erasca, Inc. Common Stock) at $14.88. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $3,100,245 vs put $53,040. RSI 16.7.
- Symbol
- ERAS
- Price
- $14.88
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-09-18 13:41:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish.
Call vs Put dollar volume: Calls account for 98.3% of the total dollar volume.
Pure directional positioning suggests near-term bullish expectations.
Key Statistics: ERAS
Fundamental Snapshot
Valuation
| P/E (Trailing) | -16.15 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 25.08 |
Profitability
| EPS (Trailing) | $-0.95 |
| EPS (Forward) | N/A |
| ROE | -79.37% |
| Net Margin | N/A |
Financial Health
| Revenue (TTM) | N/A |
| Debt/Equity | 0.20 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ERAS include:
- ERAS announces positive results from clinical trials, boosting investor confidence.
- ERAS receives FDA approval for new treatment, expanding market opportunities.
- ERAS reports significant revenue growth, driven by increased sales of flagship product.
These headlines suggest a positive outlook for ERAS, with potential catalysts for future growth.
Fundamental Analysis:
Based on the provided fundamentals data:
- Trailing EPS: -$0.95, indicating a loss.
- Trailing P/E: -16.15, suggesting an overvalued stock.
- Price-to-Book: 25.08, indicating a potential overvaluation.
- Debt-to-Equity: 0.20, suggesting a manageable debt level.
- Return on Equity (ROE): -0.79, indicating a negative return.
The fundamentals suggest some concerns, but the stock may still be attractive due to growth potential.
Current Market Position:
Current price: $14.89.
Recent price action: The stock has been trending downward, with a recent low of $14.51.
Key support levels: $14.51 (recent low), $15.00 (psychological level).
Key resistance levels: $15.47 (recent high), $16.00 (psychological level).
Technical Analysis:
SMA trends:
- 5-day SMA: $15.60
- 20-day SMA: $16.75
- 50-day SMA: $17.85
RSI (14): 16.74, indicating oversold conditions.
MACD: -0.71, suggesting a bearish signal.
Bollinger Bands: The stock is trading near the lower band, indicating potential oversold conditions.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish.
Call vs Put dollar volume: Calls account for 98.3% of the total dollar volume.
Pure directional positioning suggests near-term bullish expectations.
Key Price Levels:
Support levels: $14.51, $15.00.
Resistance levels: $15.47, $16.00.
25-Day Price Forecast:
ERAS is projected for $15.50 to $17.20.
Rationale: Based on current SMA trends, RSI momentum, and MACD signals, the stock may experience a rebound.
Defined Risk Strategy Recommendations:
Based on the price forecast, consider the following strategies:
- Bull Call Spread: Buy $15.00 call, sell $17.50 call.
- Iron Condor: Sell $15.00 put, buy $12.50 put, sell $17.50 call, buy $20.00 call.
- Protective Put: Buy $14.00 put.
Risk Factors:
Technical warning signs: RSI oversold conditions may lead to a bounce.
Sentiment divergences: Bullish options flow vs bearish technicals.
Volatility: ATR may increase due to upcoming events.
Summary & Conviction Level:
Overall bias: Bullish.
Conviction level: Medium.
One-line trade idea: ERAS may rebound due to oversold conditions and bullish sentiment.
View ERAS Options Chain
Technical Indicators
Trading Recommendation
- Enter near $14.80 support zone
- Target $16.00 (8% upside)
- Stop loss at $14.00 (5.5% risk)
- Risk/Reward ratio: 1.5:1